TCRCure Biopharma Corp is a world-class, “One-Stop Shop” cell therapy operation built across the U.S. and China. We deliver the latest cell therapy advances directly to patients with solid tumors. As of 2021, we have treated more than 50 patients and built more than a dozen CAR-T/TCR-T pipelines. TCRCure’s cutting-edge platform technologies include antigen-specific TCR/CAR discovery, immune-cell engineering, and industry-scale viral vector production. We operate 40,000 sq. ft. of specialized facilities on both sides of the Pacific, including scalable GMP capacity for cell production and viral manufacturing. TCRCure works closely with world-class hospitals in China and the United States for clinical research in different solid tumors. Current indications including cervical cancer, ovarian cancer, nasopharyngeal carcinoma, lung squamous carcinoma, melanoma, sarcoma, endometrial cancer, and brain cancer.
Company Details
- Employees
- 21
- Founded
- -
- Address
- Guangzhou, Cn
- cu****@****ure.com
- Industry
- Biotechnology
- Website
- tcrcure.com
- HQ
- Guangzhou
Tcrcure Biopharma Corp. Questions
Tcrcure Biopharma Corp.'s website is tcrcure.com
Tcrcure Biopharma Corp.'s LinkedIn profile is https://www.linkedin.com/company/tcrcure-biopharma-corp
Tcrcure Biopharma Corp. has
21 employees.
View email and phone details for 21
employees at Tcrcure Biopharma Corp..
Tcrcure Biopharma Corp.'s industry is
Biotechnology
Tcrcure Biopharma Corp.'s top competitors are
Genvivo, Inc.,
Neogene Therapeutics,
Bachem,
Atara Biotherapeutics,
A2 Biotherapeutics, Inc.,
City Of Hope,
Kite Pharma,
Symberix,
Exelint International,
Iqvia.
Tcrcure Biopharma Corp.'s support email address is customer@tcrcure.com
Tcrcure Biopharma Corp.'s categories are Biotechnology
Tcrcure Biopharma Corp.'s founding year is 2016
